Cryoport Inc (CYRX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Cryoport Inc (CYRX) has a cash flow conversion efficiency ratio of 0.002x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($919.00K) by net assets ($502.64 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cryoport Inc - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how Cryoport Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Cryoport Inc carry for a breakdown of total debt and financial obligations.
Cryoport Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cryoport Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kuo Toong International Co Ltd
TWO:8936
|
-0.017x |
|
GDI Integrated
TO:GDI
|
0.066x |
|
Kairuide Holding Co Ltd
SHE:002072
|
0.002x |
|
Helen of Troy Ltd
NASDAQ:HELE
|
0.014x |
|
Refex Industries Limited
NSE:REFEX
|
0.058x |
|
Lim Seong Hai Capital Berhad
KLSE:0351
|
0.073x |
|
Y mAbs Therapeutics
NASDAQ:YMAB
|
0.019x |
|
Tus Pharmaceutical Group Co Ltd
SHE:000590
|
0.004x |
Annual Cash Flow Conversion Efficiency for Cryoport Inc (2004–2025)
The table below shows the annual cash flow conversion efficiency of Cryoport Inc from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see Cryoport Inc market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $502.64 Million | $-8.58 Million | -0.017x | +57.97% |
| 2024-12-31 | $401.90 Million | $-16.32 Million | -0.041x | -2523.72% |
| 2023-12-31 | $489.02 Million | $-757.00K | -0.002x | +53.52% |
| 2022-12-31 | $555.84 Million | $-1.85 Million | -0.003x | -126.30% |
| 2021-12-31 | $641.83 Million | $8.13 Million | 0.013x | +132.59% |
| 2020-12-31 | $382.70 Million | $-14.87 Million | -0.039x | -270.50% |
| 2019-12-31 | $126.28 Million | $-1.32 Million | -0.010x | +87.94% |
| 2018-12-31 | $38.55 Million | $-3.35 Million | -0.087x | +56.59% |
| 2017-12-31 | $17.89 Million | $-3.58 Million | -0.200x | +80.10% |
| 2016-12-31 | $5.68 Million | $-5.72 Million | -1.007x | +20.32% |
| 2015-12-31 | $4.99 Million | $-6.31 Million | -1.264x | -112.74% |
| 2014-12-31 | $-416.30K | $-4.13 Million | 9.915x | +421.60% |
| 2013-12-31 | $-2.30 Million | $-4.38 Million | 1.901x | -18.04% |
| 2012-12-31 | $-2.06 Million | $-4.79 Million | 2.319x | +227.57% |
| 2011-12-31 | $3.73 Million | $-6.78 Million | -1.818x | -124.76% |
| 2010-12-31 | $5.95 Million | $-4.81 Million | -0.809x | -125.93% |
| 2009-12-31 | $-914.58K | $-2.85 Million | 3.120x | +344.34% |
| 2008-12-31 | $-3.68 Million | $-2.59 Million | 0.702x | +126.17% |
| 2007-12-31 | $-2.29 Million | $-710.26K | 0.310x | -47.33% |
| 2006-12-31 | $-1.96 Million | $-1.16 Million | 0.589x | +9.63% |
| 2005-12-31 | $-2.15 Million | $-1.16 Million | 0.538x | -37.68% |
| 2004-12-31 | $-1.18 Million | $-1.02 Million | 0.863x | -- |
About Cryoport Inc
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry. Its Life Sciences Products segment manufactures, and sells offers cry… Read more